GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
176 hedge funds and large institutions have $2.41B invested in Global Blood Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
176
Holders Change
+19
Holders Change %
+12.1%
% of All Funds
4.04%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.14%
New
48
Increased
63
Reduced
54
Closed
27
Calls
$56.3M
Puts
$32.2M
Net Calls
+$24M
Net Calls Change
+$3.61M
Top Buyers
Top Sellers
1 |
O
OrbiMed
New York
|
-$33.4M |
2 |
Citadel Advisors
Miami,
Florida
|
-$32.2M |
3 |
Millennium Management
New York
|
-$16.9M |
4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$13.4M |
5 |
GTC
Ghost Tree Capital
New York
|
-$12.8M |